Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2012
11/08/2012US20120282699 Mutagenesis method using polyethylene glycol mediated introduction of mutagenic nucleobases into plant protoplasts
11/08/2012US20120282698 Method for homologous recombination in eukaryotic cells
11/08/2012US20120282696 Functions and targets of let-7 micro rnas
11/08/2012US20120282695 Constructs for enhancement of gene expression in muscle
11/08/2012US20120282689 Expanding the Eukaryotic Genetic Code
11/08/2012US20120282687 Expression vector suitable for expression of a coding sequence for gene therapy
11/08/2012US20120282686 Expression vector suitable for expression of a coding sequence for gene therapy
11/08/2012US20120282685 Expression vector suitable for expression of a coding sequence for gene therapy
11/08/2012US20120282673 Functional mutation in respiratory syncytial virus
11/08/2012US20120282672 Alpha-Amylase Mutants
11/08/2012US20120282668 Genetically Programmed Expression of Proteins Containing the Unnatural Amino Acid Phenylselenocysteine
11/08/2012US20120282661 Microorganisms and methods for the biosynthesis of adipate, hexamethylenediamine and 6-aminocaproic acid
11/08/2012US20120282659 Novel beta-galactoside-alpha2,6-sialyltransferase, a gene encoding thereof, and a method for enhancing enzyme activity
11/08/2012US20120282658 Alpha-Amylase Variants and Polynucleotides Encoding Same
11/08/2012US20120282657 Enhancing spinosyn production with oxygen binding proteins
11/08/2012US20120282646 Method for activating a natural killer cell by adjusting the expression of the socs2 gene
11/08/2012US20120282643 Cyan and yellow fluorescent color variants of split gfp
11/08/2012US20120282637 Polypeptides for binding to the receptor for advanced glycation endproducts as well as compositions and methods involving
11/08/2012US20120282624 Integration of genes into the chromosome of saccharopolyspora spinosa
11/08/2012US20120282622 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
11/08/2012US20120282603 Automated system for isolating, amplifying and detecting a target nucleic acid sequence
11/08/2012US20120282322 Cochleate compositions directed against expression of proteins
11/08/2012US20120282290 Mycobacterial Vaccines
11/08/2012US20120282289 Staphylococcal antigens
11/08/2012US20120282288 Recombinant Carrier Molecule for Expression, Delivery and Purification of Target Polypeptides
11/08/2012US20120282287 Novel Flavivirus Antigens
11/08/2012US20120282286 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
11/08/2012US20120282285 Masp isoforms as inhibitors of complement activation
11/08/2012US20120282278 Anti p2x7 receptor antibodies and fragments thereof
11/08/2012US20120282274 Targeting of the c-terminal segment of c.difficile toxin b for improved clinical diagnosis, prevention, and treatment
11/08/2012US20120282271 Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
11/08/2012US20120282269 Anti-IL-23 Antibodies
11/08/2012US20120282264 Neutralizing antibodies to hiv-1 and their use
11/08/2012US20120282263 Compositions for inhibiting masp-2 dependent complement activation
11/08/2012US20120282259 Mutant smoothened and methods of using the same
11/08/2012US20120282258 Crlf2 in precursor b-cell acute lymphoblastic leukemia
11/08/2012US20120282257 Single-chain variable fragment (scfv) able to recognize and bind cd99 human protein
11/08/2012US20120282256 Chimeric receptors with 4-1bb stimulatory signaling domain
11/08/2012US20120282254 Cd127 binding proteins
11/08/2012US20120282253 Interleukin-10 antibodies
11/08/2012US20120282239 Novel mannanase variants
11/08/2012US20120282231 Human lysosomal proteins from plant cell culture
11/08/2012US20120282229 Non-viral delivery of transcription factors that reprogram human somatic cells into a stem cell-like state
11/08/2012US20120282226 Tissue Products Derived From Animals Lacking Any Expression of Functional Alpha 1, 3 Galactosyltransferase
11/08/2012US20120282225 Method and composition for creating conditional lethality for virus mutants and for eliminating the viability of an eukaryotic cell
11/08/2012US20120282217 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
11/08/2012US20120282196 Smoothened polypeptides and methods of use
11/08/2012US20120282177 ROR1 as Therapeutic and Diagnostic Target
11/08/2012US20120282170 Anti- tnf antibodies, compositions, methods and uses
11/08/2012CA2835137A1 Method for identifying antibiotic targets by complemented sequencing
11/08/2012CA2835133A1 Method for identifying antibiotic targets
11/08/2012CA2835109A1 Finite fully addressable nucleic acid nanostructures as nanocarriers for delivery of pharmaceuticals
11/08/2012CA2834945A1 Method for speeding up plant growth and improving yield by altering expression levels of kinases and phosphatases
11/08/2012CA2834865A1 Compositions and methods comprising serine protease variants
11/08/2012CA2834679A1 Plants with useful traits and related methods
11/08/2012CA2834364A1 Bacterial mrna screen strategy for novel pesticide-encoding nucleic acid molecule discovery
11/08/2012CA2834030A1 Detection of target nucleic acid sequences by po cleavage and hybridization
11/08/2012CA2834027A1 Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
11/08/2012CA2833931A1 Complement factor b analogs and their uses
11/08/2012CA2832871A1 Compositions for inhibiting masp-2 dependent complement activation
11/08/2012CA2832197A1 Als inhibitor herbicide tolerant b. napus mutants
11/08/2012CA2825163A1 Compositions for regulating iron homeostasis and methods of using same
11/07/2012EP2520659A1 Screening method
11/07/2012EP2520658A2 Enhancing spinosyn production with oxygen binding proteins
11/07/2012EP2520657A2 Modification of plant lignin content
11/07/2012EP2520656A2 Transgenic plants with increased stress tolerance and yield
11/07/2012EP2520655A2 Transgenic plants with increased stress tolerance and yield
11/07/2012EP2520654A1 Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
11/07/2012EP2520653A1 Integration of genes into the chromosome of saccharopolyspora spinosa
11/07/2012EP2520652A2 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associates genes
11/07/2012EP2520651A2 Sirna for inhibiting c-met expression and an anti-cancer composition comprising the same
11/07/2012EP2520650A2 Eukaryotic amadoriase having excellent thermal stability, gene and recombinant DNA for the eukaryotic amadoriase, and process for production of eukaryotic amadoriase having excellent thermal stability
11/07/2012EP2520649A2 MicroRNA antisense PNAs, compositions comprising the same, and methods for using and evaluating the same
11/07/2012EP2520648A1 Anti-iga1 antibody
11/07/2012EP2520647A1 Sweet taste receptor expression construct, cell body expressing same, and uses therefor
11/07/2012EP2520646A1 Phosphatidate phosphatase gene and use thereof
11/07/2012EP2520589A1 Anti-cd27 antibody
11/07/2012EP2520310A1 Cellular permissivity factor for viruses, and uses thereof
11/07/2012EP2520302A1 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
11/07/2012EP2520164A2 Transgenic pig in which ho-1 genes and tnfr1-fc genes are simultaneously expressed, and method for producing same
11/07/2012EP2519652A2 Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection
11/07/2012EP2519642A1 Recombinant thraustochytrids that grow on xylose, and compositions, methods of making, and uses thereof
11/07/2012EP2519640A1 Male and female sterility lines used to make hybrids in genetically modified plants
11/07/2012EP2519639A1 Direct and continuous root alone or root/shoot production from transgenic events derived from green regenerative tissues and its applications
11/07/2012EP2519638A2 Gpav gene resistant to nematodes in the nightshade family
11/07/2012EP2519637A2 Strains and method for the production of methionine
11/07/2012EP2519636A1 Production of hemagglutinin-neuraminidase protein in microalgae
11/07/2012EP2519635A1 Production of heterologous polypeptides in microalgae, microalgal extracellular bodies, compositions, and methods of making and uses thereof
11/07/2012EP2519634A2 TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63
11/07/2012EP2519633A2 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
11/07/2012EP2519632A2 Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3)
11/07/2012EP2519631A1 Improvements to nucleic acid elution
11/07/2012EP2519627A2 Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages
11/07/2012EP2519626A1 Modified yeast strains exhibiting enhanced fermentation of lignocellulosic hydrolysates
11/07/2012EP2519542A1 Anti-cdh3 antibodies and uses thereof
11/07/2012EP2519258A2 Recombinant ndv antigen and uses thereof
11/07/2012EP2519097A2 Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
11/07/2012EP2213737B1 Double-stranded oligonucleotides
11/07/2012CN1911960B Chlamydia protein, gene sequence and uses thereof
11/07/2012CN1524088B A virus causing respiratory tract illness in susceptible mammals